서지넥스
San Francisco, US · 2 known investors
Surginex develops lipid nanoparticle and RNA platforms for therapeutic applications, serving pharmaceutical and biotech companies in drug development.
AI & Machine LearningBiotechMedical Devices
Investors · 2
Frequently asked questions
- What does 서지넥스 do?
- Surginex develops lipid nanoparticle and RNA platforms for therapeutic applications, serving pharmaceutical and biotech companies in drug development.
- Who are 서지넥스's investors?
- 서지넥스's investors include Kiwoom Investment, Laguna Investment.
- Where is 서지넥스 headquartered?
- 서지넥스 is headquartered in San Francisco, US.